Diabetes

HTL-STREFA's Prevent DropSafe Safety Pen Needles awarded McKesson's 2019 New Product of the Year

The Prevent DropSafe Safety Pen Needle, which utilizes a thin 31-gauge needle, is McKesson's 2019 product of the year.

Lilly Expands Insulin Affordability Options

The Lilly Diabetes Solution Center can provide significant savings on Lilly insulins. Anyone who uses a Lilly insulin can contact the Lilly Diabetes Solution Center to see whether one of the additional insulins, the Lilly Insulin Value Program or another affordability option is the best financial choice for them.

Higi rolls out ADA-powered diabetes risk assessment to its health stations

Higi, in partnership with the American Diabetes Association, now is offering a free self-service Type 2 diabetes risk assessment that combines station measurements with a consumer-reported health survey.

Walgreens debuts Medicare billing solution to enable CGM access

Walgreens is rolling out a billing solution that will allow Medicare patients using Dexcom’s G6 continuous glucose monitoring device to fill their prescription at any of its 9,200 pharmacies.

Innovation in monitoring, injection, disposal benefit diabetes patients

Patients with diabetes continue to grapple with such perennial problems as blood glucose monitoring, safe injection, and disposal of the sharps they create every day.

Selfcare Roadmap Insights: Diabetes

GMDC|Retail Tomorrow and Hamacher Resource Group shared with Drug Store News some insights into the shoppers with diabetes from their new Selfcare Roadmap tool.

Owen Mumford products get thinner, more convenient

Owen Mumford recently launched Unifine Pentips Plus and the Unistik 3 Travel Lancets, as well as its thinnest pen needle ever, Unifine 33G.

Study: Regular blood glucose monitoring increases medication adherence

MILPITAS, Calif. — Blood glucose monitoring is associated with reduced A1C levels and greater adherence to medication in Type 2 diabetes patients who do not take insulin, according to a study published in the September issue of Diabetes Technology & Therapeutics.

Reimbursement pressures, product innovation threatens blood-glucose meter market

MOUNTAIN VIEW, Calif. — The market for self-monitoring blood glucose meters continues to be promising in the short term, Frost & Sullivan announced Tuesday, with $4.2 billion in revenue projected for 2016 from a 2014 base of $4 billion.

Colgate survey shows surprising lack of awareness around diabetes and oral health

Colgate Total and the American Diabetes Association teamed up to promote awareness for American Diabetes Month with a survey revealing people's knowledge — or lack thereof — about oral health and its association with diabetes.

The survey, conducted by Harris Interactive, found that 36% of respondents didn't know about the link between diabetes and oral health, and 66% of respondents didn't realize that people with diabetes are twice as likely to develop serious gum disease.

Nipro Diagnostics garners Consumer Reports recommendation for the second consecutive year

NEW YORK — Nipro Diagnostics' TRUEresult Blood Glucose Meter for the second consecutive year received a “recommended“ rating from Consumer Reports as part of the publication's review of blood glucose meters in its October issue.

The TRUEresult meter received an “excellent” rating for accuracy and “very good“ for repeatability and convenience. Additionally, the TRUE2go meter rated “very good” for accuracy and repeatability, and “good” for convenience.

Rite Aid, UnitedHealth Group offer diabetes services to Long Island, N.Y., residents

CAMP HILL, Pa. — Rite Aid pharmacists on Long Island in New York state are participating in a diabetes initiative run by health insurer UnitedHealth Group, the two companies said Thursday.

The pharmacists are part of the Diabetes Control Program, itself part of UnitedHealth's Diabetes Prevention and Control Alliance. The program is available to residents of the island enrolled in UnitedHealthcare's employer-sponsored health plans.

Report: Standards for glucose monitors may change

NEW YORK The name of the game in diabetes management is compliance. For patients and their healthcare advocates/practitioners, compliance translates into better health outcomes that will prove to be considerably less costly over the life of the patient. And for retailers and blood-glucose meter manufacturers, compliance translates into a high-frequency/high-marketbasket consumer as compared with the average pharmacy patron.

NCDP healthcare reform recommendations advocate for diabetes prevention, treatment and care

PRINCETON, N.J.